Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model

Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model

Item
http://www.wikidata.org/entity/Q35130359
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophiliaGenotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophiliaMolecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samplesInteractions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistanceStenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia.High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital.Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistanceActivities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infectionsClinical factors associated with acquisition of resistance to levofloxacin in Stenotrophomonas maltophilia.In vivo folding of recombinant metallo-beta-lactamase L1 requires the presence of Zn(II).
P2860

Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model

Item
http://www.wikidata.org/entity/Q35130359
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@ast
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@en
type
label
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@ast
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@en
prefLabel
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@ast
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932
P1433
P1476
Stenotrophomonas maltophilia: ...... pharmacodynamic chamber model
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932